Covalon Technologies (OTCMKTS:CVALF) & Vsee Health (NASDAQ:VSEE) Critical Comparison

Covalon Technologies (OTCMKTS:CVALF) and Vsee Health (NASDAQ:VSEE) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, valuation, earnings, analyst recommendations, profitability, risk and dividends.

Profitability

This table compares Covalon Technologies and Vsee Health’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Covalon Technologies	8.58%	12.33%	10.28%
Vsee Health	N/A	-182.59%	-58.26%

Earnings and Valuation

This table compares Covalon Technologies and Vsee Health”s gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Covalon Technologies	$22.91 million	2.03	$1.96 million	$0.12	14.14
Vsee Health	$6.38 million	0.64	-$4.41 million	N/A	N/A

Covalon Technologies has higher revenue and earnings than Vsee Health.

Insider & Institutional Ownership

1.0% of Vsee Health shares are held by institutional investors. 6.6% of Vsee Health shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Analyst Recommendations

This is a summary of current ratings and recommmendations for Covalon Technologies and Vsee Health, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Covalon Technologies	0	0	0	0	0.00
Vsee Health	0	0	0	1	4.00

Vsee Health has a consensus target price of $5.00, indicating a potential upside of 338.60%. Given Vsee Health’s stronger consensus rating and higher probable upside, analysts clearly believe Vsee Health is more favorable than Covalon Technologies.

Summary

Covalon Technologies beats Vsee Health on 6 of the 11 factors compared between the two stocks.

About Covalon Technologies

Covalon Technologies Ltd. engages in the research, development, manufacturing, and marketing of medical products in infection management, advanced wound care, and surgical procedure areas in the United States, Canada, the Middle East, Asia, Latin America, and internationally. The company’s platform technologies comprise collagen matrix platform that is used to manufacture a family of products to treat chronic and infected wounds, including diabetic ulcers, pressure ulcers, venous ulcers, donor and graft sites, traumatic wounds healing by secondary intention, dehisced surgical wounds, and first and second degree burns; and antimicrobial silicone adhesive platform, which is used for family of pre and post-surgical, and vascular access products that are designed to kill bacteria or yeast that comes into contact with the antimicrobial silicone providing broad-spectrum antimicrobial activity. It also offers medical coating platform, a process that utilizes photo-polymerization to create active grafting sites where new polymer chains are initiated and propagated from the surface of an existing medical device. In addition, the company provides wound care dressings; surgical and peri-operative; and infection management products. It offers its products under the Covalon brand name through third-party distribution networks and company’s direct sales force. The company serves hospitals, wound care centers, burn centers, extended/alternate care and acute care facilities, home health care agencies, and physicians’ offices. Covalon Technologies Ltd. is headquartered in Mississauga, Canada.

About Vsee Health

VSee Health, Inc. is a no-code or low-code software as a service (SaaS) platform that enables clinicians and enterprises to create their telehealth workflows without programming. It engages in providing timely, quality healthcare to patients regardless of geographical barriers. The company is headquartered in Boca Raton, FL.